Congress Wealth Management LLC DE Sells 3,683 Shares of CVS Health Co.

☀️Trending News

Congress Wealth Management LLC recently reported that it had sold 3,683 shares of CVS ($NYSE:CVS) Health Co. CVS Health is a large healthcare company that offers a broad range of services and products, including pharmaceuticals, retail stores, and health insurance. CVS Health has been a key player in the health care industry for many years and its stock is widely traded on the New York Stock Exchange. Investors have long seen CVS Health as a reliable source of income, with its stock often experiencing long-term gains as well as short-term volatility. With Congress Wealth Management LLC’s recent sale, it is likely that the company’s stock will continue to be a popular choice among investors.

Market Price

At the start of the day, the stock opened at $68.1, and at the close of the day it was trading slightly higher at $68.8, up 0.9% from its last closing price of 68.1. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Cvs Health. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Cvs Health. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Cvs Health. More…

Key Ratios Snapshot

Some of the financial key ratios for Cvs Health are shown below. More…

Analysis

As we analyze CVS HEALTH‘s financials with GoodWhale, we conclude that the company is classified as a ‘rhino’ according to our Star Chart. This type of company has achieved moderate growth in revenue or earnings, making it an attractive option for investors looking for modest returns. CVS HEALTH has a high health score of 8/10 from GoodWhale, indicating that it has the capacity to safely ride out any crisis without the risk of bankruptcy. The company also scores highly in terms of dividend, but is weaker in terms of growth, profitability, and assets. Overall, CVS HEALTH is a strong option for investors looking for moderate returns and a safe investment. Our GoodWhale analysis confirms this, giving the company a high health score and classifying it as a ‘rhino’. More…

Peers

The competition between CVS Health Corp and its competitors is fierce. Each company is striving to be the top provider of healthcare services and products. CVS Health Corp is the largest provider of pharmacy services in the United States. Marpai Inc is a close second. Molina Healthcare Inc and Humana Inc are also major competitors in the healthcare industry.

– Marpai Inc ($NASDAQ:MRAI)

Marpai Inc is a publicly traded company with a market capitalization of 20.89 million as of 2022. The company has a return on equity of -64.66%. Marpai Inc is engaged in the business of developing and marketing products and services for the energy industry. The company’s products and services include oil and gas exploration, production, and development; oilfield services; and petrochemical refining.

– Molina Healthcare Inc ($NYSE:MOH)

Molina Healthcare Inc is a health care company that provides Medicaid-related solutions for low-income families and individuals. As of 2022, the company had a market capitalization of 20.52 billion dollars and a return on equity of 24.89%. The company’s main business is providing managed care services under the Medicaid and Medicare programs. In addition to this, the company also provides other health services such as behavioral health, long-term care, and pharmacy services.

– Humana Inc ($NYSE:HUM)

Humana Inc is a healthcare company that offers a wide range of health and wellness products and services. The company has a market cap of 63.3B as of 2022 and a return on equity of 17.4%. Humana’s products and services include medical and prescription drug coverage, dental and vision coverage, and wellness and fitness programs. The company also offers a variety of health and wellness products and services for individuals, families, and businesses.

Summary

This is seen as a positive sign for CVS Health, as the company has had a successful track record of growth in recent years. The stock is currently trading at a strong price-earnings (P/E) ratio, making for an attractive investment opportunity. Moreover, the company has a healthy dividend yield and a solid balance sheet, both of which make it a safe and lucrative option for investors.

Additionally, the company benefits from a diverse product portfolio and strong customer loyalty, increasing its long-term prospects. All of this indicates that CVS Health Co. shares are likely to continue their upward trajectory in the near future.